National Health Investors, Inc. logo

National Health Investors, Inc.

NHI

NYSEReal EstateREIT - Healthcare Facilities

Previous close

$73.36

−$0.55 · -0.74%

Aug 21, 4:00 PM ET

NHI company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

69

Undervalued

Momentum

39

Weakening

Sentiment

61

Bullish

Risk resilience

72

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Established in 1991, National Health Investors, Inc. (NYSE: NHI) operates as a real estate investment trust (REIT) primarily focused on providing capital for senior living and medical real estate assets. The company facilitates this through diverse financing options, including sale-leaseback arrangements, joint ventures, and various debt instruments such as mortgage and mezzanine loans, targeting properties that cater to both essential care needs and discretionary services. NHI's broad holdings feature independent living, assisted living, and memory care facilities, as well as entrance-fee retirement communities, skilled nursing homes, medical office complexes, and specialized hospitals.

Industry
REIT - Healthcare Facilities
Sector
Real Estate
Headquarters
US
CEO
D. Eric Mendelsohn
Listed since
Oct 9, 1991
Employees
32

Market position

Day range

Current $73.36

52-week range

Current $73.36

Open
$73.985
Previous close
$73.91
Volume
224.28K
0.41× average
Average volume
549.64K
Average daily volume
Market cap
3.56B USD
Beta
0.56
Market reference 1
50-day average
$75.3964
-2.70% below average
200-day average
$78.7245
-6.81% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
4.72B USD
EV / EBITDA
16.75×
Earnings yield
3.97%
Free cash flow yield
6.15%

Profitability & efficiency

Return on equity
9.34%
Return on assets
5.08%
Return on invested capital
6.97%

Financial health

Current ratio
2.48×
Altman Z-score
1.66
Piotroski F-score
6 of 9

Earnings

EPS beat rate
55%
6 beats, 5 misses, 0 met estimates
Average EPS surprise
+0.77%
11 comparable reports
Latest EPS result
1.19
Estimate 0.84 · Beat by 41.16%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates1.611.280.950.62Q1 '25BeatQ2 '25MissQ3 '25BeatQ4 '25MissQ1 '26MissQ2 '26MissQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 25, 2025: actual 0.96, estimate 0.75, surprise +28.00%, Beat. Q2 2025, reported May 5, 2025: actual 0.75, estimate 0.76, surprise -1.32%, Miss. Q3 2025, reported Aug 6, 2025: actual 0.79, estimate 0.773, surprise +2.20%, Beat. Q4 2025, reported Nov 6, 2025: actual 0.69, estimate 1.24, surprise -44.35%, Miss. Q1 2026, reported Feb 26, 2026: actual 0.8, estimate 0.801, surprise -0.12%, Miss. Q2 2026, reported May 4, 2026: actual 0.83, estimate 1.21, surprise -31.40%, Miss. Q3 2026, reported Aug 10, 2026: actual 1.19, estimate 0.843, surprise +41.16%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 1.54, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates76.08M70.47M64.86M59.25MQ1 '25MissQ2 '25BeatQ3 '25BeatQ4 '25MissQ1 '26BeatQ2 '26BeatQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 25, 2025: actual 65.78M USD, estimate 68.15M USD, surprise -3.48%, Miss. Q2 2025, reported May 5, 2025: actual 68.87M USD, estimate 66.79M USD, surprise +3.11%, Beat. Q3 2025, reported Aug 6, 2025: actual 70.27M USD, estimate 68.34M USD, surprise +2.83%, Beat. Q4 2025, reported Nov 6, 2025: actual 62.18M USD, estimate 64.88M USD, surprise -4.17%, Miss. Q1 2026, reported Feb 26, 2026: actual 70.29M USD, estimate 69.04M USD, surprise +1.80%, Beat. Q2 2026, reported May 4, 2026: actual 73.15M USD, estimate 70.22M USD, surprise +4.18%, Beat. Q3 2026, reported Aug 10, 2026: actual 71.39M USD, estimate 72.12M USD, surprise -1.02%, Miss. Q4 2026, reported Nov 5, 2026: actual —, estimate 70.92M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

19 ratings
Strong buy00%
Buy632%
Hold1263%
Sell15%
Strong sell00%

NHI peers

ETFs holding NHI

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research NHI

research.disclaimer